Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

Huan Xia, Yin Wang, Huali Sun, Liying Gao, Yu Cao, Silvère D. Zaongo, Rong-Nan Zeng, Hao Wu, Mingjie Zhang, Ping MaChinese 2020 · DOI

Abstract

This preliminary study informs that HIV-1 INRs, allogenic NK cells immunotherapy is safe and could significantly improve CD4 recovery but not CD4/CD8 ratio. The practical effects, however, need long-term follow-up observations. Further study on the potential underlying mechanism is warranted. REGISTRATION INFO:: www.chictr.org.cn/showproj.aspx?proj=34912 (No. ChiCTR1900020634).
BibTeX
@inproceedings{xia2020safety,
  author = {Huan Xia and Yin Wang and Huali Sun and Liying Gao and Yu Cao and Silvère D. Zaongo and Rong-Nan Zeng and Hao Wu and Mingjie Zhang and Ping Ma},
  title = {{Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report}},
  booktitle = {Chinese},
  year = {2020},
  doi = {10.1097/cm9.0000000000001189},
}

Loading related content...

Figure